Half Year 2026 Talenom Earnings Call Transcript
Key Points
- Talenom PLC (OHEL:TNOM) reported a positive Q2 with good progress in key KPIs, including the successful implementation of the 'One Talenom' concept and a new software-neutral strategy that is expected to unlock significant growth potential.
- The company's profitability in Finland remained strong, with comparable EBITDA reaching EUR5.7 million (30.2% of net sales), driven by solid business performance and effective cost management.
- Sweden showed a positive profitability trend, with comparable EBITDA improving to EUR0.7 million (11.6% of net sales), thanks to successful cost adjustments and a clear path toward achieving positive EBIT this year.
- Spain delivered strong growth of 26.2% in net sales, driven by four acquisitions since Q2 2025 and steady new customer acquisition, supporting the company's expansion strategy.
- Talenom PLC (OHEL:TNOM) maintained its full-year guidance for net sales of EUR110-120 million and comparable EBITDA of EUR18-22 million, reflecting confidence in its strategic direction and operational execution.
- Talenom PLC (OHEL:TNOM)'s comparable EBITDA declined slightly in Q2 due to a EUR1.2 million impairment of trade receivables in Spain, which negatively impacted overall profitability.
- Sweden's net sales declined by 9.9% year-over-year, as high customer churn from 2025 continued to weigh on revenue, with no clear timeline for a return to growth.
- Finland's growth was weak at 1.4%, with challenging market conditions, higher customer churn, and lower activity levels in customer companies hampering organic growth.
- Spain's profitability was weighed down by acquisition integration costs and increased fixed software-related costs, which are expected to persist in the near term.
- The company noted that economic recovery in Finland and Sweden has not yet translated into higher volumes, indicating that market headwinds may continue to pressure growth in the coming quarters.
Good morning, everyone and welcome to Join Talenom's H1 release webcast.
My name is Juho Ahosola and I work as a CEO of the company and with me here today as usually is our CFO Matti Säkkinen.
¤ -
Good morning everyone and welcome on my behalf.
Okay, let's start then. Once again, welcome from my behalf as well.
Here's the agenda for this review. So, I will start with a short brief about Talenom if we have some new investors online, then. I will comment Q2 highlights as well as our development during the review period.
And then Matti will comment after me our financial performance in a bit more detailed level as well as outlook and guidance.
And at the end of this review, there's time for questions as well, which you can ask throughout the review with the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
